Loma Linda University Children's Hospital received a $48,000 grant from the St. Baldrick's Foundation to enhance access to pediatric cancer clinical trials.

Cure51's Rosalind study, approved by the NHS, will investigate biological factors behind long-term cancer survival in the UK.

Cure51's Rosalind study, approved by the NHS, will analyze tumor samples from over 1,000 cancer survivors to identify genetic and biomarker factors.

Cure51's Rosalind study, approved by the NHS, will analyze tumor samples from over 1,000 cancer survivors to identify genetic and biomarker factors.

Shionogi and Osaka Metropolitan University have established a comprehensive collaboration agreement focused on infectious disease research, diagnostics development, and public health system strengthening.

A clinical trial, backed by a £1.8 million contract, will evaluate AI-TRiPS, an AI-powered tool for trauma risk prediction, across London's trauma system.

Saint Louis University's Center for Vaccine Development will enroll up to 30 healthy adult volunteers in a Phase 1 clinical trial to evaluate the safety and immune response of an updated investigational West Nile virus vaccine.

Eli Lilly has extended its research collaboration with Purdue University through 2032, investing up to $250 million over the next eight years in what could become the largest industry-academic partnership in the United States.

Hackensack Meridian Health opened a new cancer center at JFK University Medical Center in Edison, NJ in May 2025, bringing together multiple oncology specialties under one roof.

Harvest Integrated Research Organization (HiRO) and CHA University Bundang Medical Center (CBMC) have formed a strategic partnership to enhance global clinical trials.

Eli Lilly commits $42.5M to establish a new pharmaceutical manufacturing scholarship program at Purdue University, supporting 75-100 students annually with full tuition and guaranteed internships.

IgniteData, AstraZeneca, and Cambridge University Hospitals have launched the Archer platform in a Phase 3 clinical trial, automating data transfer between electronic health records and clinical trial databases.

Israeli researchers at Hebrew University have developed a novel antibiotic eyedrop formulation using cross-linked hyaluronic acid (XHA) that significantly improves drug retention and efficacy compared to conventional carriers.

National Taiwan University Hospital (NTUH) and AbbVie Biopharmaceuticals GmbH Taiwan Branch have signed a cooperation agreement to strengthen digital strategies for clinical trials, aiming to accelerate trial approvals and improve quality. This collaboration builds on a decade-long partnership that has seen significant milestones in clinical trial research.

A new study reveals that Ellorarxine, a novel compound developed by Nevrargenics Ltd., significantly improves neuronal health in motor neurone disease (MND) patients.

A $2.1 million NCATS grant supports a multi-site study evaluating the effectiveness of remote versus in-person clinical trial methods.

Lamassu Biotech has established a collaboration with The Ohio State University to advance RABI-767, a novel therapeutic targeting acute pancreatitis in both humans and dogs.

A clinical trial of 135 participants at Indiana University demonstrated that Syrenity app users showed positive trends in reducing depression symptoms compared to non-users over a six-week period.

PharmAla Biotech has been contracted to supply its LaNeo MDMA for a clinical trial at Yale University, marking continued recognition in academic research.

The AVMA and Cornell University are collaborating on a clinical trial to address burnout among veterinary professionals, funded by AVMA and Zoetis.